Results 131 to 140 of about 2,249 (191)

Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions. [PDF]

Allergy
de Bruin-Weller MS, Boesjes CM, Achten RA, Beck LA, Irvine AD, Vestergaard C, de Graaf M, van Wijk F, Bakker DS, Weidinger S.   +9 more
europepmc   +1 more source

Risk assessment of asthma and allergic rhinitis in atopic dermatitis patients treated with biologics and JAK inhibitors: a systematic review and network meta-analysis of randomized controlled trials. [PDF]

BMC Med
Zeng L, Zhou T, Zhang L, Xian M, Zhu Z, Liu J, Fu S, Luo H, Li J.   +8 more
europepmc   +1 more source

Benign familial pemphigus treated with lebrikizumab

JAAD Case Reports
Harisankeerth Mummareddy, Nagasai C. Adusumilli, Adam J. Friedman, Christina Tolete, Joseph Zahn, Leonardo Tjahjono   +5 more
openaire   +1 more source

Efficacy and Safety of Lebrikizumab in Adult and Adolescent Patients with Skin of Color and Moderate-to-Severe Atopic Dermatitis: Results from the Phase IIIb, Open-Label ADmirable Study. [PDF]

Am J Clin Dermatol
Alexis A, Moiin A, Waibel J, Wallace P, Cohen D, Laquer V, Kwong P, Atwater AR, Schuster C, Proper J, Silk M, Pierce E, Pillai S, Rueda MJ, Moore A, ADmirable Investigators.   +15 more
europepmc   +1 more source

The molecular mechanism of the adverse effects of the biological and small molecular drugs in the therapy of inflammatory skin diseases - psoriasis and atopic dermatitis. [PDF]

Ann Med
Lemiesz P, Nowowiejska-Purpurowicz J, Flisiak I.   +2 more
europepmc   +1 more source

Tacrolimus Ophthalmic Suspension Can Be an Effective Treatment Option for Biologic-Induced Refractory Conjunctivitis. [PDF]

Cureus
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

Less can be more: The case for extended dosing intervals in biologic therapy for AD. [PDF]

J Eur Acad Dermatol Venereol
Vestergaard C.
europepmc   +1 more source

New Topical and Systemic Treatments for Atopic Dermatitis. [PDF]

Clin Exp Allergy
Mirali S, Drucker AM.
europepmc   +1 more source

Beyond the blockade: unmet needs in systemic targeted atopic dermatitis therapy. [PDF]

Front Immunol
Zhang L, Peng G, Wang M, Niyonsaba F, Gao X.   +4 more
europepmc   +1 more source